Lyme Disease Biobank Foundation

EIN: 473975911 · Portland, OR · NTEE: G80

$746KRevenue
$281KAssets
0/100Mission Score (Very Poor)
G80
Lyme Disease Biobank Foundation Financial Summary
MetricValue
Total Revenue$746K
Total Expenses$729K
Net Assets$14K

Is Lyme Disease Biobank Foundation Legit?

Insufficient Data

GoodFiling Consistency
UnknownSpending Efficiency
LimitedTransparency
NoneRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

About Lyme Disease Biobank Foundation

Lyme Disease Biobank Foundation (EIN: 473975911) is a nonprofit organization based in Portland, OR, classified under NTEE code G80. The organization reported total revenue of $746K and total assets of $281K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Lyme Disease Biobank Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

10Years Operating
SmallSize Classification
9Years of Filings
MixedRevenue Trajectory

Lyme Disease Biobank Foundation is a small nonprofit that has been operating for 10 years, with 9 years of IRS 990 filings on record (2015–2023). Revenue has grown at a compound annual rate of 19.5%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$829K
Total Expenses$729K
Surplus / Deficit+$100K
Total Assets$77K
Total Liabilities$63K
Net Assets$14K
Operating Margin12.0%
Debt-to-Asset Ratio81.5%
Months of Reserves1.3 months

Financial Health Grade: B

In 2023, Lyme Disease Biobank Foundation reported a surplus of $100K with revenue exceeding expenses, holds 1.3 months of operating reserves (limited), has a debt-to-asset ratio of 81.5% (high leverage).

Financial Trends

Over 9 years of filings (2015–2023), Lyme Disease Biobank Foundation's revenue has grown at a compound annual growth rate (CAGR) of 19.5%.

YearRevenue ChangeExpense ChangeAsset Change
2023-18.3%-23.8%-11.1%
2022+37.5%+6.5%-12.3%
2021-5.3%+9.9%-35.2%
2020-11.0%-17.7%-15.5%
2019+46.8%+45.3%-44.1%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date2016

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Analysis Pending

AI enrichment for Lyme Disease Biobank Foundation has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Lyme Disease Biobank Foundation with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$829KTotal Revenue
$729KTotal Expenses
$77KTotal Assets
$63KTotal Liabilities
$14KNet Assets
  • The organization reported a surplus of $100K, with revenue exceeding expenses.
  • Debt-to-asset ratio: 81.5%.

Frequently Asked Questions about Lyme Disease Biobank Foundation

Is Lyme Disease Biobank Foundation a legitimate charity?

Lyme Disease Biobank Foundation (EIN: 473975911) is a registered tax-exempt nonprofit based in Oregon. It has 9 years of IRS 990 filings on record. Total revenue: $746K. No red flags identified. Financial health grade: B.

How does Lyme Disease Biobank Foundation spend its money?

Lyme Disease Biobank Foundation reported $746K in total revenue in IRS 990 filings. 9 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.

Are donations to Lyme Disease Biobank Foundation tax-deductible?

Lyme Disease Biobank Foundation is registered as a tax-exempt nonprofit (EIN: 473975911). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

Where is Lyme Disease Biobank Foundation located?

Lyme Disease Biobank Foundation is headquartered in Portland, Oregon and files with the IRS under EIN 473975911. It is classified under NTEE code G80.

How many years of IRS 990 filings does Lyme Disease Biobank Foundation have?

Lyme Disease Biobank Foundation has 9 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $746K in total revenue.

Filing History

IRS 990 filing history for Lyme Disease Biobank Foundation showing financial trends over 9 years of public records:

Over 9 years of IRS 990 filings (2015–2023), Lyme Disease Biobank Foundation's revenue has grown by 314.6%, moving from $200K to $829K. Total assets increased by 789.8% over the same period, from $9K to $77K. Total functional expenses rose by 271.1%, from $197K to $729K. In its most recent filing year (2023), Lyme Disease Biobank Foundation reported a surplus of $100K, with revenue exceeding expenses. The organization holds $63K in liabilities against $77K in assets (debt-to-asset ratio: 81.5%), resulting in net assets of $14K.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $829K $729K $77K $63K
2022 $1.0M $957K $87K $173K View 990
2021 $738K $898K $99K $243K View 990
2020 $779K $818K $153K $136K View 990
2019 $875K $993K $181K $126K View 990
2018 $596K $684K $324K $150K View 990
2017 $586K $622K $354K $93K View 990
2016 $761K $417K $319K $21K View 990
2015 $200K $197K $9K $5K View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $829K, expenses of $729K, and assets of $77K (revenue -18.3% year-over-year).
  • 2022: Revenue of $1.0M, expenses of $957K, and assets of $87K (revenue +37.5% year-over-year).
  • 2021: Revenue of $738K, expenses of $898K, and assets of $99K (revenue -5.3% year-over-year).
  • 2020: Revenue of $779K, expenses of $818K, and assets of $153K (revenue -11.0% year-over-year).
  • 2019: Revenue of $875K, expenses of $993K, and assets of $181K (revenue +46.8% year-over-year).
  • 2018: Revenue of $596K, expenses of $684K, and assets of $324K (revenue +1.7% year-over-year).
  • 2017: Revenue of $586K, expenses of $622K, and assets of $354K (revenue -23.0% year-over-year).
  • 2016: Revenue of $761K, expenses of $417K, and assets of $319K (revenue +280.3% year-over-year).
  • 2015: Revenue of $200K, expenses of $197K, and assets of $9K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Lyme Disease Biobank Foundation:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing

Data Sources and Methodology

This transparency report for Lyme Disease Biobank Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in Oregon

Explore more nonprofits based in Oregon with AI-powered transparency reports.

View all Oregon nonprofits →

Similar Organizations (NTEE G80)

Other nonprofits classified under NTEE code G80.

View all G80 nonprofits →

Explore Related Nonprofits

Browse by State